NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

COVID, Free Full-Text

COVID-19 Treatment Algorithms

Efficacy Data for COVID-19

Patients, Families, and Communities COVID-19 Impact Assessment

JKMS :: Journal of Korean Medical Science

Evaluation & Management of COVID-19 in Pregnancy

Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial - The

Clinical outcomes of hospitalized COVID-19 patients treated with

COVID-19 in people with rheumatic diseases: risks, outcomes

COVID-19 and Pregnancy: Risks and Outcomes - Nursing for Women's

Science Is Answering Questions About COVID-19 and Pregnancy

Management of Patients With COVID-19

Remdesivir in pregnant women with moderate to severe coronavirus